28.37USD-2.19%Mkt Cap: 477.23M USDP/E: —Last update: 2026-06-01
Sutro Biopharma, Inc. operates as an oncology company. The company develops site-specific and novel-format antibody drug conjugates (ADCs) that enables its proprietary integrated cell-free protein synthesis platform, Xpr…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap477.23M USD
Enterprise Value352.38M USD
Revenue (TTM)102.48M USD
Gross Profit-63.93M USD
Net Income (TTM)-191.09M USD
Revenue/Share12.06 USD
Last Price28.37 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees137
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.25
PEG—
EV/EBITDA-3.61
EV/Revenue3.44
P/S4.73
P/B-1.89
EPS (TTM)-16.35
EPS (Forward)-6.88
52W Range
6.70058% of range43.85
52W High43.85 USD
52W Low6.700 USD
Profitability
Gross Margin-62.38%
Oper. Margin-288.98%
EBITDA Margin-95.26%
Profit Margin-186.45%
ROE144.27%
ROA-109.93%
Growth
Revenue Growth-21.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-177.23M USD
CapEx (TTM)1.70M USD
FCF Margin-109.67%
FCF Yield-23.55%
Net Debt-125.75M USD
Net Debt/EBITDA1.29
Balance Sheet
Debt/Equity-0.12
Current Ratio2.01
Quick Ratio1.94
Book Value/Sh-15.4300 USD
Cash/Share8.537 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateDec 3, 2025
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)47.42 USD
Target Range10.00 USD – 61.00 USD
# Analysts12
Ownership
Shares Out.16.57M
Float10.30M
Insiders2.30%
Institutions86.54%
Short Interest
Short Ratio5.0d
Short % Float7.22%
Short % Out.7.20%
Shares Short1.19M
Short (prev mo.)748.70K
Technical
SMA 5030.82 (-7.9%)
SMA 20016.73 (+69.6%)
Beta1.64
S&P 52W Chg27.70%
Avg Vol (30d)275.35K
Avg Vol (10d)421.14K
Technical Indicators
RSI (14)41.6
MACD-1.0838
MACD Signal0.1705
MACD Hist.-1.2543
BB Upper44.71 USD
BB Middle34.73 USD
BB Lower24.74 USD
BB Width57.51%
ATR (14)3.042 USD
Vol Ratio (20d)0.29x